Ausbil Investment Management’s LeMaitre Vascular LMAT Stock Holding History

Ausbil Investment Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,532	Closed	-$219K	–	74
2025 Q3	$219K	Buy	2,532 +339	+15%	+$30.3K	0.12%	66
2025 Q2	$182K	Hold	2,193	–	–	0.11%	66
2025 Q1	$184K	Hold	2,193	–	–	0.11%	56
2024 Q4	$201K	Sell	2,193 -11,053	-83%	-$1.06M	0.12%	60
2024 Q3	$1.23M	Sell	13,246 -22,740	-63%	-$1.97M	0.42%	42
2024 Q2	$2.96M	Buy	35,986 +21,341	+146%	+$1.57M	1.37%	28
2024 Q1	$966K	Sell	14,645 -2,380	-14%	-$147K	0.48%	46
2023 Q4	$966K	Buy	17,025 +3,753	+28%	+$197K	0.52%	38
2023 Q3	$732K	Buy	13,272 +5,957	+81%	+$353K	0.45%	44
2023 Q2	$492K	Buy	+7,315	New	+$446K	0.31%	45

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ausbil Investment Management's LMAT Position: Q4 2025 in Review

Ausbil Investment Management sold out of LeMaitre Vascular (LMAT) in Q4 2025, closing a stake of 2,532 shares — an estimated $219K sold.

Ausbil Investment Management first reported a position in LMAT in Q2 2023 and held it in 10 quarters. The position peaked at $2.96M in Q2 2024. 297 funds tracked by Wall St. Rank hold LMAT as of Q4 2025.

Ausbil Investment Management reported no remaining LeMaitre Vascular position as of Q4 2025 after selling out during the quarter.
Ausbil Investment Management sold 2,532 LeMaitre Vascular shares in Q4 2025, an estimated $219K.
Ausbil Investment Management first reported a position in LeMaitre Vascular in Q2 2023 and held it in 10 quarters.
Ausbil Investment Management's LeMaitre Vascular position peaked at $2.96M in Q2 2024.
297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2025.

Based on Ausbil Investment Management's 13F filing for Q4 2025, filed 13 Jan 2026.